Cargando…
Recent Progress on Lipid Intake and Chronic Kidney Disease
The incidence of chronic kidney disease (CKD) is associated with major abnormalities in circulating lipoproteins and renal lipid metabolism. This article elaborates on the mechanisms of CKD and lipid uptake abnormalities. The viewpoint we supported is that lipid abnormalities directly cause CKD, res...
Autores principales: | Pei, Ke, Gui, Ting, Li, Chao, Zhang, Qian, Feng, Huichao, Li, Yunlun, Wu, Jibiao, Gai, Zhibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196967/ https://www.ncbi.nlm.nih.gov/pubmed/32382547 http://dx.doi.org/10.1155/2020/3680397 |
Ejemplares similares
-
An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020) -
The Role of Mitochondria in Drug-Induced Kidney Injury
por: Gai, Zhibo, et al.
Publicado: (2020) -
Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle
por: Zhang, Shijun, et al.
Publicado: (2021) -
Author Correction: Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p
por: Li, Chao, et al.
Publicado: (2020) -
Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p
por: Li, Chao, et al.
Publicado: (2020)